Clinical Trial Update: A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Post-marketing safety study of dorzagliatin in patients with type 2 diabetes (Phase 4) ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dorzagliatin (dorzagliatin)

Snippet

Sponsor: Hua Medicine Limited | Conditions: Type2diabetes | Phase 4 | Status: RECRUITING